Heart-type Fatty Acid Binding Protein
- UID
- IMP/IVD/2022/000117_957c14849ac1a553d94998cf64a8b9e3_b3b8c988178be092aa4cebd9b541f491
- Device class
- Class C
- Brand name
- eCLIA
- Approving authority
- CDSCO
- Product information
- Immunoassay for in vitro quantitative determination of H-FABP in human serum and plasma. Clinically used for the auxiliary diagnosis of acute myocardial infarction
Heart-type Fatty Acid Binding Protein is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000117_957c14849ac1a553d94998cf64a8b9e3_b3b8c988178be092aa4cebd9b541f491. This device is marketed under the brand name eCLIA. The license holder is Q-Line Biotech Private Limited (Formerly Known As POCT SERVICES PRIVATE LIMITED), and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.